nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—CYP1A1—Clobetasol propionate—psoriasis	0.194	0.259	CbGbCtD
Prazosin—CYP1A1—Methoxsalen—psoriasis	0.102	0.136	CbGbCtD
Prazosin—CYP1A1—Cholecalciferol—psoriasis	0.0674	0.0902	CbGbCtD
Prazosin—ABCG2—Mycophenolate mofetil—psoriasis	0.0633	0.0847	CbGbCtD
Prazosin—ABCG2—Hydrocortisone—psoriasis	0.0508	0.068	CbGbCtD
Prazosin—ABCG2—Cyclosporine—psoriasis	0.048	0.0642	CbGbCtD
Prazosin—ABCG2—Dexamethasone—psoriasis	0.0316	0.0423	CbGbCtD
Prazosin—CYP1A1—Dexamethasone—psoriasis	0.0292	0.039	CbGbCtD
Prazosin—ABCG2—Methotrexate—psoriasis	0.0254	0.034	CbGbCtD
Prazosin—ABCB1—Mycophenolate mofetil—psoriasis	0.0228	0.0305	CbGbCtD
Prazosin—ABCB1—Betamethasone—psoriasis	0.0196	0.0262	CbGbCtD
Prazosin—ABCB1—Prednisolone—psoriasis	0.0193	0.0259	CbGbCtD
Prazosin—ABCB1—Hydrocortisone—psoriasis	0.0183	0.0245	CbGbCtD
Prazosin—ABCB1—Prednisone—psoriasis	0.0182	0.0244	CbGbCtD
Prazosin—ABCB1—Cyclosporine—psoriasis	0.0173	0.0232	CbGbCtD
Prazosin—ABCB1—Dexamethasone—psoriasis	0.0114	0.0152	CbGbCtD
Prazosin—ABCB1—Methotrexate—psoriasis	0.00916	0.0123	CbGbCtD
Prazosin—Loss of consciousness—Hydrocortisone—psoriasis	0.000328	0.00132	CcSEcCtD
Prazosin—Pancreatitis—Methotrexate—psoriasis	0.000327	0.00132	CcSEcCtD
Prazosin—Tachycardia—Mycophenolate mofetil—psoriasis	0.000327	0.00132	CcSEcCtD
Prazosin—Ill-defined disorder—Triamcinolone—psoriasis	0.000326	0.00132	CcSEcCtD
Prazosin—Bradycardia—Prednisone—psoriasis	0.000325	0.00131	CcSEcCtD
Prazosin—Alopecia—Dexamethasone—psoriasis	0.000324	0.00131	CcSEcCtD
Prazosin—Alopecia—Betamethasone—psoriasis	0.000324	0.00131	CcSEcCtD
Prazosin—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000323	0.0013	CcSEcCtD
Prazosin—Vomiting—Hydroxyurea—psoriasis	0.000322	0.0013	CcSEcCtD
Prazosin—Discomfort—Prednisolone—psoriasis	0.000322	0.0013	CcSEcCtD
Prazosin—Abdominal discomfort—Methotrexate—psoriasis	0.00032	0.00129	CcSEcCtD
Prazosin—Rash—Hydroxyurea—psoriasis	0.000319	0.00129	CcSEcCtD
Prazosin—Dermatitis—Hydroxyurea—psoriasis	0.000319	0.00129	CcSEcCtD
Prazosin—Hallucination—Prednisone—psoriasis	0.000318	0.00128	CcSEcCtD
Prazosin—Malaise—Triamcinolone—psoriasis	0.000317	0.00128	CcSEcCtD
Prazosin—Headache—Hydroxyurea—psoriasis	0.000317	0.00128	CcSEcCtD
Prazosin—Vertigo—Triamcinolone—psoriasis	0.000316	0.00127	CcSEcCtD
Prazosin—Syncope—Triamcinolone—psoriasis	0.000315	0.00127	CcSEcCtD
Prazosin—Discomfort—Hydrocortisone—psoriasis	0.000314	0.00127	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000312	0.00126	CcSEcCtD
Prazosin—Oedema—Prednisolone—psoriasis	0.000312	0.00126	CcSEcCtD
Prazosin—Insomnia—Cyclosporine—psoriasis	0.00031	0.00125	CcSEcCtD
Prazosin—Loss of consciousness—Triamcinolone—psoriasis	0.000309	0.00125	CcSEcCtD
Prazosin—Paraesthesia—Cyclosporine—psoriasis	0.000308	0.00124	CcSEcCtD
Prazosin—Shock—Prednisolone—psoriasis	0.000307	0.00124	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—psoriasis	0.000307	0.00124	CcSEcCtD
Prazosin—Dyspnoea—Cyclosporine—psoriasis	0.000306	0.00123	CcSEcCtD
Prazosin—Somnolence—Cyclosporine—psoriasis	0.000305	0.00123	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000305	0.00123	CcSEcCtD
Prazosin—Oedema—Hydrocortisone—psoriasis	0.000305	0.00123	CcSEcCtD
Prazosin—Tachycardia—Prednisolone—psoriasis	0.000305	0.00123	CcSEcCtD
Prazosin—Asthenia—Mycophenolic acid—psoriasis	0.000304	0.00123	CcSEcCtD
Prazosin—Insomnia—Mycophenolate mofetil—psoriasis	0.000303	0.00122	CcSEcCtD
Prazosin—Hyperhidrosis—Prednisolone—psoriasis	0.000302	0.00122	CcSEcCtD
Prazosin—Nausea—Hydroxyurea—psoriasis	0.000301	0.00121	CcSEcCtD
Prazosin—Paraesthesia—Mycophenolate mofetil—psoriasis	0.0003	0.00121	CcSEcCtD
Prazosin—Pruritus—Mycophenolic acid—psoriasis	0.0003	0.00121	CcSEcCtD
Prazosin—Shock—Hydrocortisone—psoriasis	0.0003	0.00121	CcSEcCtD
Prazosin—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000298	0.0012	CcSEcCtD
Prazosin—Tachycardia—Hydrocortisone—psoriasis	0.000297	0.0012	CcSEcCtD
Prazosin—Somnolence—Mycophenolate mofetil—psoriasis	0.000297	0.0012	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—psoriasis	0.000297	0.0012	CcSEcCtD
Prazosin—Flushing—Prednisone—psoriasis	0.000296	0.00119	CcSEcCtD
Prazosin—Ill-defined disorder—Dexamethasone—psoriasis	0.000296	0.00119	CcSEcCtD
Prazosin—Ill-defined disorder—Betamethasone—psoriasis	0.000296	0.00119	CcSEcCtD
Prazosin—Discomfort—Triamcinolone—psoriasis	0.000296	0.00119	CcSEcCtD
Prazosin—Fatigue—Cyclosporine—psoriasis	0.000296	0.00119	CcSEcCtD
Prazosin—Hyperhidrosis—Hydrocortisone—psoriasis	0.000295	0.00119	CcSEcCtD
Prazosin—Constipation—Cyclosporine—psoriasis	0.000293	0.00118	CcSEcCtD
Prazosin—Pain—Cyclosporine—psoriasis	0.000293	0.00118	CcSEcCtD
Prazosin—Dry mouth—Triamcinolone—psoriasis	0.000293	0.00118	CcSEcCtD
Prazosin—Diarrhoea—Mycophenolic acid—psoriasis	0.00029	0.00117	CcSEcCtD
Prazosin—Malaise—Dexamethasone—psoriasis	0.000288	0.00116	CcSEcCtD
Prazosin—Malaise—Betamethasone—psoriasis	0.000288	0.00116	CcSEcCtD
Prazosin—Oedema—Triamcinolone—psoriasis	0.000287	0.00116	CcSEcCtD
Prazosin—Vertigo—Dexamethasone—psoriasis	0.000287	0.00116	CcSEcCtD
Prazosin—Vertigo—Betamethasone—psoriasis	0.000287	0.00116	CcSEcCtD
Prazosin—Syncope—Betamethasone—psoriasis	0.000286	0.00115	CcSEcCtD
Prazosin—Syncope—Dexamethasone—psoriasis	0.000286	0.00115	CcSEcCtD
Prazosin—Pain—Mycophenolate mofetil—psoriasis	0.000286	0.00115	CcSEcCtD
Prazosin—Constipation—Mycophenolate mofetil—psoriasis	0.000286	0.00115	CcSEcCtD
Prazosin—Feeling abnormal—Cyclosporine—psoriasis	0.000283	0.00114	CcSEcCtD
Prazosin—Shock—Triamcinolone—psoriasis	0.000282	0.00114	CcSEcCtD
Prazosin—Insomnia—Prednisolone—psoriasis	0.000282	0.00114	CcSEcCtD
Prazosin—Alopecia—Prednisone—psoriasis	0.000282	0.00114	CcSEcCtD
Prazosin—Loss of consciousness—Betamethasone—psoriasis	0.00028	0.00113	CcSEcCtD
Prazosin—Loss of consciousness—Dexamethasone—psoriasis	0.00028	0.00113	CcSEcCtD
Prazosin—Dizziness—Mycophenolic acid—psoriasis	0.00028	0.00113	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—psoriasis	0.00028	0.00113	CcSEcCtD
Prazosin—Paraesthesia—Prednisolone—psoriasis	0.00028	0.00113	CcSEcCtD
Prazosin—Tachycardia—Triamcinolone—psoriasis	0.00028	0.00113	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000278	0.00112	CcSEcCtD
Prazosin—Hyperhidrosis—Triamcinolone—psoriasis	0.000277	0.00112	CcSEcCtD
Prazosin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000276	0.00111	CcSEcCtD
Prazosin—Insomnia—Hydrocortisone—psoriasis	0.000276	0.00111	CcSEcCtD
Prazosin—Paraesthesia—Hydrocortisone—psoriasis	0.000274	0.0011	CcSEcCtD
Prazosin—Urticaria—Cyclosporine—psoriasis	0.000272	0.0011	CcSEcCtD
Prazosin—Body temperature increased—Cyclosporine—psoriasis	0.000271	0.00109	CcSEcCtD
Prazosin—Vomiting—Mycophenolic acid—psoriasis	0.00027	0.00109	CcSEcCtD
Prazosin—Discomfort—Betamethasone—psoriasis	0.000268	0.00108	CcSEcCtD
Prazosin—Discomfort—Dexamethasone—psoriasis	0.000268	0.00108	CcSEcCtD
Prazosin—Rash—Mycophenolic acid—psoriasis	0.000267	0.00108	CcSEcCtD
Prazosin—Dermatitis—Mycophenolic acid—psoriasis	0.000267	0.00108	CcSEcCtD
Prazosin—Pain—Prednisolone—psoriasis	0.000267	0.00108	CcSEcCtD
Prazosin—Urticaria—Mycophenolate mofetil—psoriasis	0.000266	0.00107	CcSEcCtD
Prazosin—Headache—Mycophenolic acid—psoriasis	0.000266	0.00107	CcSEcCtD
Prazosin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000264	0.00107	CcSEcCtD
Prazosin—Fatigue—Hydrocortisone—psoriasis	0.000263	0.00106	CcSEcCtD
Prazosin—Vision blurred—Prednisone—psoriasis	0.000262	0.00106	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000261	0.00105	CcSEcCtD
Prazosin—Pain—Hydrocortisone—psoriasis	0.000261	0.00105	CcSEcCtD
Prazosin—Oedema—Dexamethasone—psoriasis	0.00026	0.00105	CcSEcCtD
Prazosin—Oedema—Betamethasone—psoriasis	0.00026	0.00105	CcSEcCtD
Prazosin—Insomnia—Triamcinolone—psoriasis	0.00026	0.00105	CcSEcCtD
Prazosin—Ill-defined disorder—Prednisone—psoriasis	0.000258	0.00104	CcSEcCtD
Prazosin—Paraesthesia—Triamcinolone—psoriasis	0.000258	0.00104	CcSEcCtD
Prazosin—Feeling abnormal—Prednisolone—psoriasis	0.000257	0.00104	CcSEcCtD
Prazosin—Shock—Betamethasone—psoriasis	0.000256	0.00103	CcSEcCtD
Prazosin—Shock—Dexamethasone—psoriasis	0.000256	0.00103	CcSEcCtD
Prazosin—Dyspnoea—Triamcinolone—psoriasis	0.000256	0.00103	CcSEcCtD
Prazosin—Tachycardia—Dexamethasone—psoriasis	0.000254	0.00102	CcSEcCtD
Prazosin—Tachycardia—Betamethasone—psoriasis	0.000254	0.00102	CcSEcCtD
Prazosin—Hypersensitivity—Cyclosporine—psoriasis	0.000253	0.00102	CcSEcCtD
Prazosin—Nausea—Mycophenolic acid—psoriasis	0.000252	0.00102	CcSEcCtD
Prazosin—Hyperhidrosis—Dexamethasone—psoriasis	0.000252	0.00101	CcSEcCtD
Prazosin—Hyperhidrosis—Betamethasone—psoriasis	0.000252	0.00101	CcSEcCtD
Prazosin—Feeling abnormal—Hydrocortisone—psoriasis	0.000251	0.00101	CcSEcCtD
Prazosin—Malaise—Prednisone—psoriasis	0.000251	0.00101	CcSEcCtD
Prazosin—Vertigo—Prednisone—psoriasis	0.00025	0.00101	CcSEcCtD
Prazosin—Syncope—Prednisone—psoriasis	0.000249	0.001	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—psoriasis	0.000249	0.001	CcSEcCtD
Prazosin—Urticaria—Prednisolone—psoriasis	0.000248	0.001	CcSEcCtD
Prazosin—Fatigue—Triamcinolone—psoriasis	0.000247	0.000998	CcSEcCtD
Prazosin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000247	0.000994	CcSEcCtD
Prazosin—Asthenia—Cyclosporine—psoriasis	0.000246	0.000992	CcSEcCtD
Prazosin—Pain—Triamcinolone—psoriasis	0.000245	0.000989	CcSEcCtD
Prazosin—Loss of consciousness—Prednisone—psoriasis	0.000244	0.000985	CcSEcCtD
Prazosin—Pruritus—Cyclosporine—psoriasis	0.000243	0.000978	CcSEcCtD
Prazosin—Urticaria—Hydrocortisone—psoriasis	0.000242	0.000976	CcSEcCtD
Prazosin—Body temperature increased—Hydrocortisone—psoriasis	0.000241	0.000971	CcSEcCtD
Prazosin—Asthenia—Mycophenolate mofetil—psoriasis	0.00024	0.000968	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000237	0.000956	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000237	0.000956	CcSEcCtD
Prazosin—Pruritus—Mycophenolate mofetil—psoriasis	0.000237	0.000954	CcSEcCtD
Prazosin—Arthralgia—Prednisone—psoriasis	0.000237	0.000954	CcSEcCtD
Prazosin—Feeling abnormal—Triamcinolone—psoriasis	0.000237	0.000953	CcSEcCtD
Prazosin—Alopecia—Methotrexate—psoriasis	0.000236	0.00095	CcSEcCtD
Prazosin—Insomnia—Dexamethasone—psoriasis	0.000236	0.00095	CcSEcCtD
Prazosin—Insomnia—Betamethasone—psoriasis	0.000236	0.00095	CcSEcCtD
Prazosin—Diarrhoea—Cyclosporine—psoriasis	0.000235	0.000946	CcSEcCtD
Prazosin—Paraesthesia—Dexamethasone—psoriasis	0.000234	0.000943	CcSEcCtD
Prazosin—Paraesthesia—Betamethasone—psoriasis	0.000234	0.000943	CcSEcCtD
Prazosin—Discomfort—Prednisone—psoriasis	0.000234	0.000942	CcSEcCtD
Prazosin—Hypersensitivity—Prednisolone—psoriasis	0.00023	0.000927	CcSEcCtD
Prazosin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000229	0.000923	CcSEcCtD
Prazosin—Urticaria—Triamcinolone—psoriasis	0.000228	0.000919	CcSEcCtD
Prazosin—Body temperature increased—Triamcinolone—psoriasis	0.000227	0.000915	CcSEcCtD
Prazosin—Dizziness—Cyclosporine—psoriasis	0.000227	0.000914	CcSEcCtD
Prazosin—Oedema—Prednisone—psoriasis	0.000227	0.000914	CcSEcCtD
Prazosin—Hypersensitivity—Hydrocortisone—psoriasis	0.000225	0.000905	CcSEcCtD
Prazosin—Fatigue—Dexamethasone—psoriasis	0.000225	0.000905	CcSEcCtD
Prazosin—Fatigue—Betamethasone—psoriasis	0.000225	0.000905	CcSEcCtD
Prazosin—Shock—Prednisone—psoriasis	0.000223	0.000899	CcSEcCtD
Prazosin—Pain—Dexamethasone—psoriasis	0.000223	0.000898	CcSEcCtD
Prazosin—Pain—Betamethasone—psoriasis	0.000223	0.000898	CcSEcCtD
Prazosin—Tachycardia—Prednisone—psoriasis	0.000221	0.000892	CcSEcCtD
Prazosin—Dizziness—Mycophenolate mofetil—psoriasis	0.000221	0.000892	CcSEcCtD
Prazosin—Hyperhidrosis—Prednisone—psoriasis	0.000219	0.000884	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—psoriasis	0.000219	0.000882	CcSEcCtD
Prazosin—Asthenia—Hydrocortisone—psoriasis	0.000219	0.000882	CcSEcCtD
Prazosin—Vomiting—Cyclosporine—psoriasis	0.000218	0.000879	CcSEcCtD
Prazosin—Rash—Cyclosporine—psoriasis	0.000216	0.000872	CcSEcCtD
Prazosin—Dermatitis—Cyclosporine—psoriasis	0.000216	0.000871	CcSEcCtD
Prazosin—Pruritus—Hydrocortisone—psoriasis	0.000216	0.000869	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—psoriasis	0.000215	0.000869	CcSEcCtD
Prazosin—Headache—Cyclosporine—psoriasis	0.000215	0.000866	CcSEcCtD
Prazosin—Feeling abnormal—Betamethasone—psoriasis	0.000215	0.000865	CcSEcCtD
Prazosin—Feeling abnormal—Dexamethasone—psoriasis	0.000215	0.000865	CcSEcCtD
Prazosin—Vomiting—Mycophenolate mofetil—psoriasis	0.000213	0.000858	CcSEcCtD
Prazosin—Hypersensitivity—Triamcinolone—psoriasis	0.000211	0.000852	CcSEcCtD
Prazosin—Rash—Mycophenolate mofetil—psoriasis	0.000211	0.00085	CcSEcCtD
Prazosin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000211	0.00085	CcSEcCtD
Prazosin—Headache—Mycophenolate mofetil—psoriasis	0.00021	0.000845	CcSEcCtD
Prazosin—Malaise—Methotrexate—psoriasis	0.000209	0.000844	CcSEcCtD
Prazosin—Vertigo—Methotrexate—psoriasis	0.000209	0.000841	CcSEcCtD
Prazosin—Diarrhoea—Hydrocortisone—psoriasis	0.000209	0.000841	CcSEcCtD
Prazosin—Urticaria—Dexamethasone—psoriasis	0.000207	0.000834	CcSEcCtD
Prazosin—Urticaria—Betamethasone—psoriasis	0.000207	0.000834	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000207	0.000833	CcSEcCtD
Prazosin—Dizziness—Prednisolone—psoriasis	0.000206	0.000832	CcSEcCtD
Prazosin—Asthenia—Triamcinolone—psoriasis	0.000206	0.00083	CcSEcCtD
Prazosin—Body temperature increased—Dexamethasone—psoriasis	0.000206	0.00083	CcSEcCtD
Prazosin—Body temperature increased—Betamethasone—psoriasis	0.000206	0.00083	CcSEcCtD
Prazosin—Insomnia—Prednisone—psoriasis	0.000205	0.000827	CcSEcCtD
Prazosin—Nausea—Cyclosporine—psoriasis	0.000204	0.000821	CcSEcCtD
Prazosin—Paraesthesia—Prednisone—psoriasis	0.000204	0.000821	CcSEcCtD
Prazosin—Pruritus—Triamcinolone—psoriasis	0.000203	0.000819	CcSEcCtD
Prazosin—Dizziness—Hydrocortisone—psoriasis	0.000202	0.000813	CcSEcCtD
Prazosin—Nausea—Mycophenolate mofetil—psoriasis	0.000199	0.000801	CcSEcCtD
Prazosin—Arthralgia—Methotrexate—psoriasis	0.000198	0.000797	CcSEcCtD
Prazosin—Rash—Prednisolone—psoriasis	0.000197	0.000793	CcSEcCtD
Prazosin—Dermatitis—Prednisolone—psoriasis	0.000197	0.000793	CcSEcCtD
Prazosin—Fatigue—Prednisone—psoriasis	0.000196	0.000788	CcSEcCtD
Prazosin—Headache—Prednisolone—psoriasis	0.000196	0.000788	CcSEcCtD
Prazosin—Discomfort—Methotrexate—psoriasis	0.000195	0.000787	CcSEcCtD
Prazosin—Constipation—Prednisone—psoriasis	0.000194	0.000782	CcSEcCtD
Prazosin—Vomiting—Hydrocortisone—psoriasis	0.000194	0.000781	CcSEcCtD
Prazosin—Rash—Hydrocortisone—psoriasis	0.000192	0.000775	CcSEcCtD
Prazosin—Dermatitis—Hydrocortisone—psoriasis	0.000192	0.000774	CcSEcCtD
Prazosin—Headache—Hydrocortisone—psoriasis	0.000191	0.00077	CcSEcCtD
Prazosin—Dizziness—Triamcinolone—psoriasis	0.00019	0.000765	CcSEcCtD
Prazosin—Feeling abnormal—Prednisone—psoriasis	0.000187	0.000753	CcSEcCtD
Prazosin—Asthenia—Betamethasone—psoriasis	0.000187	0.000753	CcSEcCtD
Prazosin—Asthenia—Dexamethasone—psoriasis	0.000187	0.000753	CcSEcCtD
Prazosin—Nausea—Prednisolone—psoriasis	0.000185	0.000747	CcSEcCtD
Prazosin—Pruritus—Betamethasone—psoriasis	0.000184	0.000743	CcSEcCtD
Prazosin—Pruritus—Dexamethasone—psoriasis	0.000184	0.000743	CcSEcCtD
Prazosin—Hyperhidrosis—Methotrexate—psoriasis	0.000183	0.000739	CcSEcCtD
Prazosin—Vomiting—Triamcinolone—psoriasis	0.000182	0.000736	CcSEcCtD
Prazosin—Nausea—Hydrocortisone—psoriasis	0.000181	0.00073	CcSEcCtD
Prazosin—Rash—Triamcinolone—psoriasis	0.000181	0.00073	CcSEcCtD
Prazosin—Dermatitis—Triamcinolone—psoriasis	0.000181	0.000729	CcSEcCtD
Prazosin—Urticaria—Prednisone—psoriasis	0.00018	0.000726	CcSEcCtD
Prazosin—Headache—Triamcinolone—psoriasis	0.00018	0.000725	CcSEcCtD
Prazosin—Body temperature increased—Prednisone—psoriasis	0.000179	0.000723	CcSEcCtD
Prazosin—Diarrhoea—Dexamethasone—psoriasis	0.000178	0.000718	CcSEcCtD
Prazosin—Diarrhoea—Betamethasone—psoriasis	0.000178	0.000718	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000173	0.000696	CcSEcCtD
Prazosin—Dizziness—Dexamethasone—psoriasis	0.000172	0.000694	CcSEcCtD
Prazosin—Dizziness—Betamethasone—psoriasis	0.000172	0.000694	CcSEcCtD
Prazosin—Insomnia—Methotrexate—psoriasis	0.000171	0.000691	CcSEcCtD
Prazosin—Nausea—Triamcinolone—psoriasis	0.00017	0.000687	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—psoriasis	0.00017	0.000686	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—psoriasis	0.000169	0.000681	CcSEcCtD
Prazosin—Somnolence—Methotrexate—psoriasis	0.000169	0.000679	CcSEcCtD
Prazosin—Hypersensitivity—Prednisone—psoriasis	0.000167	0.000674	CcSEcCtD
Prazosin—Vomiting—Betamethasone—psoriasis	0.000166	0.000667	CcSEcCtD
Prazosin—Vomiting—Dexamethasone—psoriasis	0.000166	0.000667	CcSEcCtD
Prazosin—Rash—Dexamethasone—psoriasis	0.000164	0.000662	CcSEcCtD
Prazosin—Rash—Betamethasone—psoriasis	0.000164	0.000662	CcSEcCtD
Prazosin—Dermatitis—Betamethasone—psoriasis	0.000164	0.000661	CcSEcCtD
Prazosin—Dermatitis—Dexamethasone—psoriasis	0.000164	0.000661	CcSEcCtD
Prazosin—Fatigue—Methotrexate—psoriasis	0.000163	0.000659	CcSEcCtD
Prazosin—Headache—Betamethasone—psoriasis	0.000163	0.000658	CcSEcCtD
Prazosin—Headache—Dexamethasone—psoriasis	0.000163	0.000658	CcSEcCtD
Prazosin—Asthenia—Prednisone—psoriasis	0.000163	0.000656	CcSEcCtD
Prazosin—Pain—Methotrexate—psoriasis	0.000162	0.000653	CcSEcCtD
Prazosin—Pruritus—Prednisone—psoriasis	0.00016	0.000647	CcSEcCtD
Prazosin—Feeling abnormal—Methotrexate—psoriasis	0.000156	0.00063	CcSEcCtD
Prazosin—Diarrhoea—Prednisone—psoriasis	0.000155	0.000626	CcSEcCtD
Prazosin—Nausea—Betamethasone—psoriasis	0.000155	0.000624	CcSEcCtD
Prazosin—Nausea—Dexamethasone—psoriasis	0.000155	0.000624	CcSEcCtD
Prazosin—Urticaria—Methotrexate—psoriasis	0.000151	0.000607	CcSEcCtD
Prazosin—Dizziness—Prednisone—psoriasis	0.00015	0.000605	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—psoriasis	0.00015	0.000604	CcSEcCtD
Prazosin—Vomiting—Prednisone—psoriasis	0.000144	0.000581	CcSEcCtD
Prazosin—Rash—Prednisone—psoriasis	0.000143	0.000576	CcSEcCtD
Prazosin—Dermatitis—Prednisone—psoriasis	0.000143	0.000576	CcSEcCtD
Prazosin—Headache—Prednisone—psoriasis	0.000142	0.000573	CcSEcCtD
Prazosin—Hypersensitivity—Methotrexate—psoriasis	0.00014	0.000563	CcSEcCtD
Prazosin—Asthenia—Methotrexate—psoriasis	0.000136	0.000548	CcSEcCtD
Prazosin—Nausea—Prednisone—psoriasis	0.000135	0.000543	CcSEcCtD
Prazosin—Pruritus—Methotrexate—psoriasis	0.000134	0.000541	CcSEcCtD
Prazosin—Diarrhoea—Methotrexate—psoriasis	0.00013	0.000523	CcSEcCtD
Prazosin—Dizziness—Methotrexate—psoriasis	0.000125	0.000505	CcSEcCtD
Prazosin—Vomiting—Methotrexate—psoriasis	0.000121	0.000486	CcSEcCtD
Prazosin—Rash—Methotrexate—psoriasis	0.00012	0.000482	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—psoriasis	0.000119	0.000481	CcSEcCtD
Prazosin—Headache—Methotrexate—psoriasis	0.000119	0.000479	CcSEcCtD
Prazosin—Nausea—Methotrexate—psoriasis	0.000113	0.000454	CcSEcCtD
Prazosin—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	8.87e-06	0.0019	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—NDUFA5—psoriasis	8.8e-06	0.00189	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CCL20—psoriasis	8.8e-06	0.00189	CbGpPWpGaD
Prazosin—KCNH2—SIDS Susceptibility Pathways—TNF—psoriasis	8.78e-06	0.00188	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	8.78e-06	0.00188	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TAGAP—psoriasis	8.67e-06	0.00186	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HCAR2—psoriasis	8.56e-06	0.00184	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	8.46e-06	0.00181	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	8.37e-06	0.0018	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—ITGAL—psoriasis	8.29e-06	0.00178	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CCL20—psoriasis	8.29e-06	0.00178	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	8.18e-06	0.00175	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CYP2S1—psoriasis	8.11e-06	0.00174	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	8.07e-06	0.00173	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CYP2S1—psoriasis	8.03e-06	0.00172	CbGpPWpGaD
Prazosin—ABCB1—Allograft Rejection—IFNG—psoriasis	7.97e-06	0.00171	CbGpPWpGaD
Prazosin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	7.96e-06	0.00171	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—CXCL8—psoriasis	7.91e-06	0.0017	CbGpPWpGaD
Prazosin—ADRA1A—AMPK Signaling—TP53—psoriasis	7.89e-06	0.00169	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	7.8e-06	0.00167	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HCAR2—psoriasis	7.73e-06	0.00166	CbGpPWpGaD
Prazosin—HTR1D—G alpha (i) signalling events—CXCL8—psoriasis	7.64e-06	0.00164	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CCL20—psoriasis	7.53e-06	0.00161	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CCL20—psoriasis	7.48e-06	0.00161	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CYP2S1—psoriasis	7.48e-06	0.00161	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HCAR2—psoriasis	7.46e-06	0.0016	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—NDUFA5—psoriasis	7.46e-06	0.0016	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TAGAP—psoriasis	7.42e-06	0.00159	CbGpPWpGaD
Prazosin—ABCB1—Allograft Rejection—CXCL8—psoriasis	7.41e-06	0.00159	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—JUN—psoriasis	7.36e-06	0.00158	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CCL20—psoriasis	7.23e-06	0.00155	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HCAR2—psoriasis	7.11e-06	0.00152	CbGpPWpGaD
Prazosin—KCNH2—SIDS Susceptibility Pathways—IL6—psoriasis	7.09e-06	0.00152	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—NFKB1—psoriasis	7.08e-06	0.00152	CbGpPWpGaD
Prazosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	6.95e-06	0.00149	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CCL20—psoriasis	6.88e-06	0.00148	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CCL20—psoriasis	6.8e-06	0.00146	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TAGAP—psoriasis	6.7e-06	0.00144	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	6.7e-06	0.00144	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CCL20—psoriasis	6.56e-06	0.00141	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TAGAP—psoriasis	6.47e-06	0.00139	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NDUFA5—psoriasis	6.46e-06	0.00139	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—VEGFA—psoriasis	6.43e-06	0.00138	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CYP2S1—psoriasis	6.34e-06	0.00136	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HCAR2—psoriasis	6.31e-06	0.00135	CbGpPWpGaD
Prazosin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	6.3e-06	0.00135	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—CARM1—psoriasis	6.25e-06	0.00134	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CCL20—psoriasis	6.25e-06	0.00134	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TAGAP—psoriasis	6.16e-06	0.00132	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CCL20—psoriasis	6.11e-06	0.00131	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	6.11e-06	0.00131	CbGpPWpGaD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	6.08e-06	0.0013	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.02e-06	0.00129	CbGpPWpGaD
Prazosin—ABCB1—Allograft Rejection—VEGFA—psoriasis	6.02e-06	0.00129	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	5.95e-06	0.00128	CbGpPWpGaD
Prazosin—ADRA2B—G alpha (i) signalling events—CXCL8—psoriasis	5.91e-06	0.00127	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HCAR2—psoriasis	5.87e-06	0.00126	CbGpPWpGaD
Prazosin—HTR1A—G alpha (i) signalling events—CXCL8—psoriasis	5.7e-06	0.00122	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CCL20—psoriasis	5.68e-06	0.00122	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCL20—psoriasis	5.55e-06	0.00119	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—TNF—psoriasis	5.51e-06	0.00118	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CYP2S1—psoriasis	5.49e-06	0.00118	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TAGAP—psoriasis	5.47e-06	0.00117	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	5.2e-06	0.00112	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCL20—psoriasis	5.2e-06	0.00111	CbGpPWpGaD
Prazosin—ABCB1—Allograft Rejection—TNF—psoriasis	5.16e-06	0.00111	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NDUFA5—psoriasis	5.16e-06	0.00111	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCL20—psoriasis	5.16e-06	0.00111	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	5.13e-06	0.0011	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TAGAP—psoriasis	5.09e-06	0.00109	CbGpPWpGaD
Prazosin—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—psoriasis	5.04e-06	0.00108	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	4.79e-06	0.00103	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.7e-06	0.00101	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—CXCL8—psoriasis	4.63e-06	0.000993	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	4.57e-06	0.000981	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.53e-06	0.000972	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—NOS2—psoriasis	4.48e-06	0.000962	CbGpPWpGaD
Prazosin—ADRA2A—G alpha (i) signalling events—CXCL8—psoriasis	4.48e-06	0.000961	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL20—psoriasis	4.45e-06	0.000954	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—IL6—psoriasis	4.45e-06	0.000954	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP2S1—psoriasis	4.39e-06	0.000941	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.32e-06	0.000926	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL20—psoriasis	4.02e-06	0.000861	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CARM1—psoriasis	3.96e-06	0.00085	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—CXCL8—psoriasis	3.96e-06	0.00085	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	3.95e-06	0.000846	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CARM1—psoriasis	3.92e-06	0.000841	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL20—psoriasis	3.88e-06	0.000831	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—CAT—psoriasis	3.85e-06	0.000825	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.84e-06	0.000823	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	3.82e-06	0.00082	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL20—psoriasis	3.69e-06	0.000792	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CARM1—psoriasis	3.65e-06	0.000784	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—CXCL8—psoriasis	3.58e-06	0.000767	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.56e-06	0.000764	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—CXCL8—psoriasis	3.45e-06	0.000741	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—NOS2—psoriasis	3.4e-06	0.00073	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	3.4e-06	0.000729	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—CXCL8—psoriasis	3.29e-06	0.000705	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL20—psoriasis	3.28e-06	0.000703	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	3.28e-06	0.000703	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.27e-06	0.000702	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CARM1—psoriasis	3.1e-06	0.000664	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL20—psoriasis	3.05e-06	0.000653	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—APOE—psoriasis	2.99e-06	0.000641	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.97e-06	0.000637	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—CXCL8—psoriasis	2.92e-06	0.000626	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.91e-06	0.000624	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.88e-06	0.000617	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SOCS1—psoriasis	2.86e-06	0.000614	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—TYK2—psoriasis	2.73e-06	0.000585	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	2.71e-06	0.000582	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CARM1—psoriasis	2.68e-06	0.000575	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—CXCL8—psoriasis	2.62e-06	0.000561	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PPARG—psoriasis	2.6e-06	0.000558	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—VEGFA—psoriasis	2.6e-06	0.000557	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.55e-06	0.000546	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.51e-06	0.000538	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SOCS1—psoriasis	2.45e-06	0.000525	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CAT—psoriasis	2.44e-06	0.000523	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CAT—psoriasis	2.41e-06	0.000517	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CXCL8—psoriasis	2.38e-06	0.000509	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—TYK2—psoriasis	2.34e-06	0.000501	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CAT—psoriasis	2.25e-06	0.000482	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.25e-06	0.000482	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CXCL8—psoriasis	2.24e-06	0.00048	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SOCS1—psoriasis	2.21e-06	0.000474	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CARM1—psoriasis	2.14e-06	0.000459	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SOCS1—psoriasis	2.13e-06	0.000458	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—LEP—psoriasis	2.11e-06	0.000453	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—APOE—psoriasis	2.11e-06	0.000453	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—TYK2—psoriasis	2.11e-06	0.000452	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—TYK2—psoriasis	2.04e-06	0.000436	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	2.03e-06	0.000436	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SOCS1—psoriasis	2.03e-06	0.000436	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	2.02e-06	0.000434	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—VEGFA—psoriasis	1.97e-06	0.000423	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NFKBIA—psoriasis	1.97e-06	0.000422	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—TP53—psoriasis	1.96e-06	0.000421	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.95e-06	0.000418	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—TYK2—psoriasis	1.94e-06	0.000416	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CAT—psoriasis	1.91e-06	0.000409	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—APOE—psoriasis	1.89e-06	0.000406	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—APOE—psoriasis	1.87e-06	0.000402	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	1.86e-06	0.000399	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	1.84e-06	0.000394	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—LEP—psoriasis	1.81e-06	0.000388	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—APOE—psoriasis	1.81e-06	0.000388	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.81e-06	0.000387	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.77e-06	0.00038	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—APOE—psoriasis	1.75e-06	0.000375	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.72e-06	0.000369	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.69e-06	0.000362	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	1.68e-06	0.000361	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.68e-06	0.00036	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.65e-06	0.000354	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CAT—psoriasis	1.65e-06	0.000354	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PPARG—psoriasis	1.65e-06	0.000354	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PPARG—psoriasis	1.63e-06	0.00035	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—LEP—psoriasis	1.63e-06	0.00035	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—APOE—psoriasis	1.63e-06	0.00035	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TYK2—psoriasis	1.61e-06	0.000346	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.6e-06	0.000343	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—APOE—psoriasis	1.58e-06	0.000338	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—LEP—psoriasis	1.58e-06	0.000338	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.53e-06	0.000329	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PPARG—psoriasis	1.52e-06	0.000326	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	1.52e-06	0.000326	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—APOE—psoriasis	1.5e-06	0.000322	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—LEP—psoriasis	1.5e-06	0.000322	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	1.5e-06	0.000321	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—TP53—psoriasis	1.49e-06	0.000319	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—APOE—psoriasis	1.48e-06	0.000318	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.47e-06	0.000315	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CXCL8—psoriasis	1.4e-06	0.000301	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	1.4e-06	0.0003	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	1.39e-06	0.000299	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TYK2—psoriasis	1.38e-06	0.000296	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL6—psoriasis	1.33e-06	0.000286	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOE—psoriasis	1.33e-06	0.000286	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—LEP—psoriasis	1.33e-06	0.000286	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CAT—psoriasis	1.32e-06	0.000283	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—JUN—psoriasis	1.3e-06	0.00028	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PPARG—psoriasis	1.29e-06	0.000277	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOE—psoriasis	1.28e-06	0.000275	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NFKB1—psoriasis	1.26e-06	0.000269	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TYK2—psoriasis	1.25e-06	0.000267	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	1.24e-06	0.000266	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—LEP—psoriasis	1.24e-06	0.000266	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOE—psoriasis	1.24e-06	0.000266	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TYK2—psoriasis	1.2e-06	0.000258	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL8—psoriasis	1.2e-06	0.000258	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	1.15e-06	0.000247	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TYK2—psoriasis	1.14e-06	0.000246	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL6—psoriasis	1.14e-06	0.000245	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—psoriasis	1.14e-06	0.000244	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—STAT3—psoriasis	1.13e-06	0.000242	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—JUN—psoriasis	1.12e-06	0.000239	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PPARG—psoriasis	1.12e-06	0.000239	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL8—psoriasis	1.08e-06	0.000233	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NFKB1—psoriasis	1.07e-06	0.000231	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.05e-06	0.000225	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL6—psoriasis	1.03e-06	0.000221	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOE—psoriasis	1.02e-06	0.00022	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TYK2—psoriasis	1.02e-06	0.000218	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—JUN—psoriasis	1.01e-06	0.000216	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL8—psoriasis	9.97e-07	0.000214	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL6—psoriasis	9.95e-07	0.000213	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—psoriasis	9.75e-07	0.000209	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—JUN—psoriasis	9.73e-07	0.000209	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NFKB1—psoriasis	9.7e-07	0.000208	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—STAT3—psoriasis	9.66e-07	0.000207	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL6—psoriasis	9.48e-07	0.000203	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TYK2—psoriasis	9.45e-07	0.000203	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NFKB1—psoriasis	9.37e-07	0.000201	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—JUN—psoriasis	9.27e-07	0.000199	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NFKB1—psoriasis	8.92e-07	0.000191	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPARG—psoriasis	8.92e-07	0.000191	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL8—psoriasis	8.85e-07	0.00019	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—psoriasis	8.81e-07	0.000189	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—STAT3—psoriasis	8.72e-07	0.000187	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TP53—psoriasis	8.61e-07	0.000185	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—psoriasis	8.5e-07	0.000182	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL6—psoriasis	8.42e-07	0.000181	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—STAT3—psoriasis	8.42e-07	0.000181	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—JUN—psoriasis	8.23e-07	0.000177	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL8—psoriasis	8.23e-07	0.000176	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—psoriasis	8.1e-07	0.000174	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—STAT3—psoriasis	8.02e-07	0.000172	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NFKB1—psoriasis	7.92e-07	0.00017	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL6—psoriasis	7.88e-07	0.000169	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6—psoriasis	7.82e-07	0.000168	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—JUN—psoriasis	7.65e-07	0.000164	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TP53—psoriasis	7.37e-07	0.000158	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NFKB1—psoriasis	7.36e-07	0.000158	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—psoriasis	7.19e-07	0.000154	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—STAT3—psoriasis	7.12e-07	0.000153	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6—psoriasis	6.75e-07	0.000145	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—psoriasis	6.68e-07	0.000143	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TP53—psoriasis	6.65e-07	0.000143	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STAT3—psoriasis	6.62e-07	0.000142	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TP53—psoriasis	6.42e-07	0.000138	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TP53—psoriasis	6.12e-07	0.000131	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6—psoriasis	6.09e-07	0.000131	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6—psoriasis	5.88e-07	0.000126	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6—psoriasis	5.6e-07	0.00012	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TP53—psoriasis	5.43e-07	0.000117	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TP53—psoriasis	5.05e-07	0.000108	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6—psoriasis	4.97e-07	0.000107	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6—psoriasis	4.62e-07	9.91e-05	CbGpPWpGaD
